ZyrCold Tablet is a combination medication containing Cetirizine 5mg and Ambroxol 60mg, formulated to provide effective relief from symptoms associated with allergic rhinitis and respiratory tract disorders. Cetirizine, a second-generation antihistamine, selectively inhibits peripheral H1 histamine receptors, thereby alleviating allergic symptoms such as sneezing, nasal congestion, runny nose, and itching. Ambroxol acts as a mucolytic agent, enhancing mucus clearance by breaking down mucus viscosity and stimulating ciliary activity in the respiratory tract, which facilitates expectoration and improves breathing. This dual-action formulation is particularly beneficial in managing conditions where allergic reactions are accompanied by excessive mucus production, such as in allergic bronchitis or upper respiratory tract infections. ZyrCold Tablet is generally well tolerated, with a low incidence of sedation due to the non-sedative profile of Cetirizine. It is indicated for adults and children above 12 years of age. The recommended dosage should be adhered to as per medical advice to avoid potential side effects. Patients with known hypersensitivity to either component or with severe hepatic or renal impairment should consult a healthcare professional before use. ZyrCold Tablet offers a comprehensive approach to symptomatic relief, improving patient comfort and respiratory function.